ASD Among Its Peers
End-of-day Nov 17, 2026 · 0 ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −2.7% | +1.6% | −5.0% | — | — | — | — | +10.1% |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | — |
$36 of every $1,000 in ASD is Acadia
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ACHCAcadia Healthcare | Healthcare | 3.60% | $359.77 | 1,276 | $49K |
| 2 | HLUN-B.COH Lundbeck A/S | Healthcare | 3.49% | $348.81 | 5,296 | $48K |
| 3 | LLYEli Lilly | Healthcare | 3.34% | $333.78 | 32 | $46K |
| 4 | 4506.TSumitomo Pharma | Healthcare | 3.32% | $331.69 | 3,600 | $46K |
| 5 | BTSGBrightSpring Health Services | Healthcare | 3.27% | $326.55 | 628 | $45K |
| 6 | RVTYRevvity | Healthcare | 3.25% | $325.34 | 300 | $45K |
| 7 | 4502.TTakeda Pharmaceutical | Healthcare | 3.17% | $316.72 | 1,000 | $43K |
| 8 | TEVA.TATeva Pharmaceutical Industries | Healthcare | 3.17% | $316.54 | 996 | $43K |
| 9 | NOVN.SWNovartis AG | Healthcare | 3.11% | $311.17 | 264 | $43K |
| 10 | ROP.SWRoche AG | Healthcare | 3.06% | $305.61 | 86 | $42K |
| 11 | ABBVAbbVie | Healthcare | 3.05% | $304.73 | 142 | $42K |
| 12 | GHCGraham | Industrials | 3.00% | $300.47 | 32 | $41K |
| 13 | 4507.TShionogi | Healthcare | 2.96% | $295.67 | 2,000 | $41K |
| 14 | LFSTLifeStance Health Group | Healthcare | 2.95% | $295.18 | 2,798 | $41K |
| 15 | PSON.LPearson | Communication Services | 2.94% | $294.19 | 2,320 | $40K |
ASD has no close peers in our data yet: […]
Not enough history yet: ASD needs a year of prices.
Estimated yearly cost excludes trading costs and assumes constant assets.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ACHC | Acadia Healthcare | 3.60% |
| 2 | HLUN-B.CO | H Lundbeck A/S | 3.49% |
| 3 | LLY | Eli Lilly & | 3.34% |
| 4 | 4506.T | Sumitomo Pharma | 3.32% |
| 5 | BTSG | BrightSpring Health Services | 3.27% |
| 6 | RVTY | Revvity | 3.25% |
| 7 | 4502.T | Takeda Pharmaceutical | 3.17% |
| 8 | TEVA.TA | Teva Pharmaceutical Industries | 3.17% |
| 9 | NOVN.SW | Novartis AG | 3.11% |
| 10 | ROP.SW | Roche AG | 3.06% |
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 24, 2026 | $0.0020 |
| Jun 24, 2026 | Jun 25, 2026 | $0.0060 |